Haemonetics stockHAE
Haemonetics trades at $117.47, 11.0% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +46.6% year to date, +75.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Feb 11, 2027.
Ratings, candles, signals and the screener for HAE — after you log in
Open the terminalFrequently asked questions about Haemonetics
What is the Haemonetics stock price?
At 11:22 ET on Nov 6, 2026: $117.47 (−5.35% on the day). 52-week high: $132.00 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Haemonetics report earnings?
The next quarterly report is on Feb 11, 2027. Last quarter, earnings per share changed +6% year over year, revenue +9%.
Does Haemonetics pay dividends?
No, Haemonetics does not pay dividends.
Where does Haemonetics trade and how to buy it?
Ticker HAE, exchange NYSE, listed since 1991. You can buy it through a broker with access to US exchanges.
Should I buy Haemonetics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for HAE are in the terminal after you log in.